{"id":8353,"date":"2021-03-24T12:04:40","date_gmt":"2021-03-24T01:04:40","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?p=8353"},"modified":"2021-03-24T12:05:07","modified_gmt":"2021-03-24T01:05:07","slug":"statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/mvec.mcri.edu.au\/vi\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/","title":{"rendered":"Tuy\u00ean b\u1ed1 c\u1ee7a ti\u1ec3u ban COVID-19 c\u1ee7a \u1ee6y ban C\u1ed1 v\u1ea5n To\u00e0n c\u1ea7u c\u1ee7a WHO v\u1ec1 An to\u00e0n V\u1eafc xin (GACVS) v\u1ec1 c\u00e1c d\u1ea5u hi\u1ec7u an to\u00e0n li\u00ean quan \u0111\u1ebfn v\u1eafc xin COVID-19 c\u1ee7a AstraZeneca"},"content":{"rendered":"

The WHO Global Advisory Committee on Vaccine Safety (GACVS) subcommittee on safety signals related to AstraZeneca COVID-19 vaccine have released a statement on recent reports of thromboembolic and thrombocytopenic events following vaccination with the AstraZeneca COVID-19 vaccine.<\/p>\n

The committee notes that as of 17 March 2021 there have more than 120 million cases of COVID-19 infections and more than 2 million deaths worldwide. To date, more than 20 million doses of the AstraZeneca vaccine have been administered in Europe and more than 27 million doses of the Covishield, the AstraZeneca vaccine by the Serum Institute of India, have been administered in India.<\/p>\n

They found that the vaccine continues to have a positive risk\/benefit profile and that clotting conditions such as deep venous thrombosis or pulmonary embolism events have not increased following receiving this vaccine. In relation to reports of rare thromboembolic events such as cerebral venous sinus thrombosis, they note a causal relationship has not been established (the European Medicines Agency [EMA] have reviewed 18 cases of CVST out of more than 20 million doses of the AstraZeneca COVID-19 vaccine in Europe). \u00a0The committee recommend that countries continue to monitor the safety of all COVID-19 vaccines and that healthcare workers should be educated in recognising signs and symptoms of adverse events following vaccination and agree with the EMA\u2019s plans to investigate these events further.<\/p>\n

Read the full statement below, including links to the EMA statement and the UK MHRA statement<\/p>\n

WHO: Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Ti\u1ec3u ban c\u1ee7a \u1ee6y ban C\u1ed1 v\u1ea5n To\u00e0n c\u1ea7u v\u1ec1 An to\u00e0n V\u1eafc xin (GACVS) c\u1ee7a WHO v\u1ec1 c\u00e1c t\u00edn hi\u1ec7u an to\u00e0n li\u00ean quan \u0111\u1ebfn v\u1eafc xin AstraZeneca COVID-19 \u0111\u00e3 \u0111\u01b0a ra tuy\u00ean b\u1ed1 v\u1ec1 c\u00e1c b\u00e1o c\u00e1o g\u1ea7n \u0111\u00e2y v\u1ec1 c\u00e1c bi\u1ebfn c\u1ed1 thuy\u00ean t\u1eafc huy\u1ebft kh\u1ed1i v\u00e0 gi\u1ea3m ti\u1ec3u c\u1ea7u sau khi ti\u00eam v\u1eafc xin AstraZeneca COVID-19.<\/p>","protected":false},"author":493,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"","_lmt_disable":"","footnotes":"","_wp_rev_ctl_limit":""},"categories":[87,8,10],"tags":[],"class_list":["post-8353","post","type-post","status-publish","format-standard","hentry","category-news","category-covid-19","category-external"],"acf":[],"yoast_head":"\nStatement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine - The Melbourne Vaccine Education Centre (MVEC)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mvec.mcri.edu.au\/vi\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine - The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"og:description\" content=\"The WHO Global Advisory Committee on Vaccine Safety (GACVS) subcommittee on safety signals related to AstraZeneca COVID-19 vaccine have released a statement on recent reports of thromboembolic and thrombocytopenic events following vaccination with the AstraZeneca COVID-19 vaccine.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mvec.mcri.edu.au\/vi\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-24T01:04:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-24T01:05:07+00:00\" \/>\n<meta name=\"author\" content=\"Alice Black\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alice Black\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\\\/\"},\"author\":{\"name\":\"Alice Black\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"headline\":\"Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine\",\"datePublished\":\"2021-03-24T01:04:40+00:00\",\"dateModified\":\"2021-03-24T01:05:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\\\/\"},\"wordCount\":279,\"commentCount\":0,\"articleSection\":[\"Show all\",\"COVID-19\",\"External News\"],\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\\\/\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\\\/\",\"name\":\"Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine - The Melbourne Vaccine Education Centre (MVEC)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\"},\"datePublished\":\"2021-03-24T01:04:40+00:00\",\"dateModified\":\"2021-03-24T01:05:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\",\"name\":\"The Melbourne Vaccine Education Centre (MVEC)\",\"description\":\"Find all your vaccine related infos here.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\",\"name\":\"Alice Black\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/vi\\\/author\\\/alice-black\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine - The Melbourne Vaccine Education Centre (MVEC)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mvec.mcri.edu.au\/vi\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/","og_locale":"vi_VN","og_type":"article","og_title":"Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine - The Melbourne Vaccine Education Centre (MVEC)","og_description":"The WHO Global Advisory Committee on Vaccine Safety (GACVS) subcommittee on safety signals related to AstraZeneca COVID-19 vaccine have released a statement on recent reports of thromboembolic and thrombocytopenic events following vaccination with the AstraZeneca COVID-19 vaccine.","og_url":"https:\/\/mvec.mcri.edu.au\/vi\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/","og_site_name":"The Melbourne Vaccine Education Centre (MVEC)","article_published_time":"2021-03-24T01:04:40+00:00","article_modified_time":"2021-03-24T01:05:07+00:00","author":"Alice Black","twitter_card":"summary_large_image","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"Alice Black","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"2 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mvec.mcri.edu.au\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/#article","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/"},"author":{"name":"Alice Black","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"headline":"Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine","datePublished":"2021-03-24T01:04:40+00:00","dateModified":"2021-03-24T01:05:07+00:00","mainEntityOfPage":{"@id":"https:\/\/mvec.mcri.edu.au\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/"},"wordCount":279,"commentCount":0,"articleSection":["Show all","COVID-19","External News"],"inLanguage":"vi","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mvec.mcri.edu.au\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mvec.mcri.edu.au\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/","url":"https:\/\/mvec.mcri.edu.au\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/","name":"Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine - The Melbourne Vaccine Education Centre (MVEC)","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/#website"},"datePublished":"2021-03-24T01:04:40+00:00","dateModified":"2021-03-24T01:05:07+00:00","author":{"@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"breadcrumb":{"@id":"https:\/\/mvec.mcri.edu.au\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mvec.mcri.edu.au\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mvec.mcri.edu.au\/statement-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mvec.mcri.edu.au\/"},{"@type":"ListItem","position":2,"name":"Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine"}]},{"@type":"WebSite","@id":"https:\/\/mvec.mcri.edu.au\/#website","url":"https:\/\/mvec.mcri.edu.au\/","name":"Trung t\u00e2m gi\u00e1o d\u1ee5c v\u1eafc xin Melbourne (MVEC)","description":"T\u00ecm t\u1ea5t c\u1ea3 c\u00e1c th\u00f4ng tin li\u00ean quan \u0111\u1ebfn v\u1eafc-xin c\u1ee7a b\u1ea1n \u1edf \u0111\u00e2y.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mvec.mcri.edu.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Person","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311","name":"Alice \u0111en","url":"https:\/\/mvec.mcri.edu.au\/vi\/author\/alice-black\/"}]}},"modified_by":null,"_links":{"self":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/8353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/users\/493"}],"replies":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/comments?post=8353"}],"version-history":[{"count":0,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/8353\/revisions"}],"wp:attachment":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/media?parent=8353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/categories?post=8353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/tags?post=8353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}